Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...

This disruption to Germany’s position as the leader in pharmaceuticals ... as the century progresses. Vertex's gene-editing therapy for sickle cell disease, Casgevy, has been given the nod ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.